
Inflammatory Bowel Disease and Gut Microbiota
Current Strategies and Future Prospects in Nanomedicine
- English
- ePUB (mobile friendly)
- Available on iOS & Android
Inflammatory Bowel Disease and Gut Microbiota
Current Strategies and Future Prospects in Nanomedicine
About this book
This new volume delves into the extensive new research on inflammatory bowel disease (IBD) and gut microbiota that has led to effective therapeutic interventions. Highlighting novel methodologies and innovative treatment approaches, the book provides a comprehensive investigation of IBD, exploring the significance of gut microbiota and investigating the fundamental role of microbial imbalances in the initiation and progression of inflammatory processes as well as the prominent therapeutic consequences of restoring microbial homeostasis. From nanoparticle-based drug delivery systems that advance the bioavailability of the medicament to the use of bio-nanosensors for early detection of disease, the book covers a broad spectrum of inventions that hold potential for revolutionizing IBD treatment. The authors look at the impact of nutraceuticals, probiotics, prebiotics, functional foods, oral siRNA-based nanomedicine, and other novel drug delivery systems on gut microbiota for the management of IBD. The book also explores the role of reactive oxygen species (ROSs), superoxide dismutases (SODs), and inflammation in association with gut microbiota and IBD.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover Page
- Half Title page
- Title Page
- Copyright Page
- About the Editors
- Contents
- Contributors
- Abbreviations
- Acknowledgments
- Preface
- Introduction
- Chapter 1 Introduction to Gut Microbiota and Inflammatory Bowel Disease: A Systematic Review
- Chapter 2 Pathogenesis of Gut Microbiota in Inflammatory Bowel Disease
- Chapter 3 Impact of Nutraceuticals on Gut Microbiota for the Management of Inflammatory Bowel Disease
- Chapter 4 Targeting Gut Microbiota with a Novel Drug Delivery System to Treat Inflammatory Bowel Disease
- Chapter 5 Management of Gut MicrobiotaDerived Bacterial Metabolites Induced Inflammatory Bowel Disease
- Chapter 6 Correlation Between Host Genetics and Gut Microbiota in Inflammatory Bowel Disease
- Chapter 7 Oral siRNA-Based Nanomedicine for the Treatment of Inflammatory Bowel Disease
- Chapter 8 Site Specific Targeted Novel Drug Delivery System for the Management of Inflammatory Bowel Disease
- Chapter 9 Surface Modified Lipid Nanoparticle-Mediated Site-Specific Drug Delivery for Inflammatory Bowel Disease
- Chapter 10 Interplay Between Autophagy, Gut Microbiota and Inflammatory Bowel Disease
- Chapter 11 Role of Reactive Oxygen Species, Superoxide Dismutases, and Inflammation in Association with Gut Microbiota and Inflammatory Bowel Disease
- Chapter 12 Composition of Gut Microbiota Dysbiosis and Functional Food to Treat Inflammatory Bowel Disease
- Chapter 13 Age-Related Gut Dysbiosis and Its Impact on Inflammatory Bowel Disease
- Chapter 14 Impact of Diseased Condition on Gut Microbiota in Inflammatory Bowel Disease
- Chapter 15 Role of Probiotics and Prebiotics in Inflammatory Bowel Disease
- Chapter 16 Application of Natural Products to Target Gut Microbiota for Inflammatory Bowel Disease Management
- Chapter 17 Future Prospects and Patents of Nanomedicines to Treat Inflammatory Bowel Disease
- Index